The SINTABAC FRANCHISE came about due to the petition of various patients who had experienced the success of the treatment and noticed the high potential it had as a business.
SINTABAC belongs to the Spanish company, SINTABAC SL which began as a treatment centre in 1999.
SINTABAC is a registered trade mark and is registered in the National Franchise Register in Spain.
Should you require any further information please by email our customer service on infor@sintabacs.es
SINTABAC belongs to the Spanish company, SINTABAC SL which began as a treatment centre in 1999.
SINTABAC is a registered trade mark and is registered in the National Franchise Register in Spain.
Should you require any further information please by email our customer service on infor@sintabacs.es
f
On the 10th June 2008, the Colegio Sagrada Familia with the collaboration of the Centro Laser Sintabac de Granada organised a conference about tobacco addiction with the 2nd and 3rd year students.
The conference was taken by the director of Centro Sintabac de Granada, Mr Juan A Rama.
The conference objective was two-fold: firstly, to make the students aware of the adverse health consequences of tobacco and secondly, prevent tobacco addiction amongst adolescents.
The presentation and commentary by the director of SINTABAC was followed with great interest by the 180 students who were in attendance.
Due to the success of this conference and the positive reactions from both the students and teachers we have been asked to carry out courses during the following term, including 1st and 4th year students.
We would like to express our gratitude to the director of the college, Sister Monserrat and to the students for their interest in the prevention of tobacco addiction.
A well-known company from Jaen, Orejera Espuny Castellar, can be extremely proud that it is a company that without smoke – yes, that’s right! Without smoke! What you can see in the background of the photograph is nothing more than water vapour.
The entire 17 strong workforce underwent treatment and therapy to give-up smoking during the 13th, 14th and 15th of June 2008 and achieved a 100% success rate.
We would like to express our gratitude to the board of the company and in particular, the company manager Mr Fernando Muñoz Hoyo for having the confidence in SINTABAC to enable the company employees to give-up smoking.
The Asociación de Fibromialgia (Fibromyalgia) de Andujar, in collaboration with Centro Laser Sintabac, has undergone treatment so that its members and families can give-up smoking.
They underwent therapy on the 9th, 10th and 11th of May 2008 with spectacular results – all patients treated gave-up smoking.
Due to the success of the treatment, the Asociación de Fibromialgia de Andujar intends to organise treatment for more of its members and families.
We would like to take this opportunity to encourage you all to undergo treatment so that you can beat tobacco addiction.
Will-power alone is usually not enough to enable you to give-up smoking.
According to a new scientific study, it is the genes that principally determine if a person will respond better or worse to anti-tobacco programmes and indeed, if he/she is predisposed to do so.
This discovery is “without precedents” according to the investigation team who also hope that this study will provide a solution to substance dependence.
At this moment is time, the investigation team hold that at least 30 identified genes intervene in the control on drug dependence.
Scientists from the American National Institute on Drug Abuse, with the collaboration of Duke University have mapped-out, for the first time, a genetic sequence formed by hundreds of genes that allow us to predict how a smoker will respond to the different anti-tobacco treatments, above all those that replace nicotine addiction through pills, patches or gum over weekly or monthly periods.
Using the same method, the positive response to Bupropion, a common antidepressant that although doesn’t contain nicotine is used to contain nicotine anxiety by influencing the compensation circuits of the brain, can also be predicted.
Now investigators have more evidence that there exists a biological base not only for addiction but also for the capacity of a smoker to successfully give-up their addiction.
According to information published by “Time” magazine compiled by otr/press, scientists strongly advise professionals to also recommend therapy to smokers who wish to beat the habit of smoking.
Scientists also indicate that one method of stimulating the smoker patient in the process of treatment is to work with a “partner” that is also undergoing anti-nicotine treatment. This is in fact, the system being carried out in the study directed by Jed Rose, director of Duke University.
In this study, Rose and his team have studied 520,000 individual genes taken from smokers and non-smokers blood samples and determined that there is a gene profile that is implicated in the probability of a smoker being successful in breaking the nicotine habit.
The publication specifically highlights that some genes influence in the communication with the brain; others code broken enzymes in the body depending upon the anti-nicotine method used, that is to say, each of these genes “…have the same function; to help give-up smoking although each one does so in a different way”. “In this way, people whose genes code enzymes more efficiently respond better to medication” said the director of the study, whilst people with variant genetics which improve cell communication, have a higher disposition, in general to give-up smoking.
The conference was taken by the director of Centro Sintabac de Granada, Mr Juan A Rama.
The conference objective was two-fold: firstly, to make the students aware of the adverse health consequences of tobacco and secondly, prevent tobacco addiction amongst adolescents.
The presentation and commentary by the director of SINTABAC was followed with great interest by the 180 students who were in attendance.
Due to the success of this conference and the positive reactions from both the students and teachers we have been asked to carry out courses during the following term, including 1st and 4th year students.
We would like to express our gratitude to the director of the college, Sister Monserrat and to the students for their interest in the prevention of tobacco addiction.
A well-known company from Jaen, Orejera Espuny Castellar, can be extremely proud that it is a company that without smoke – yes, that’s right! Without smoke! What you can see in the background of the photograph is nothing more than water vapour.
The entire 17 strong workforce underwent treatment and therapy to give-up smoking during the 13th, 14th and 15th of June 2008 and achieved a 100% success rate.
We would like to express our gratitude to the board of the company and in particular, the company manager Mr Fernando Muñoz Hoyo for having the confidence in SINTABAC to enable the company employees to give-up smoking.
The Asociación de Fibromialgia (Fibromyalgia) de Andujar, in collaboration with Centro Laser Sintabac, has undergone treatment so that its members and families can give-up smoking.
They underwent therapy on the 9th, 10th and 11th of May 2008 with spectacular results – all patients treated gave-up smoking.
Due to the success of the treatment, the Asociación de Fibromialgia de Andujar intends to organise treatment for more of its members and families.
We would like to take this opportunity to encourage you all to undergo treatment so that you can beat tobacco addiction.
Will-power alone is usually not enough to enable you to give-up smoking.
According to a new scientific study, it is the genes that principally determine if a person will respond better or worse to anti-tobacco programmes and indeed, if he/she is predisposed to do so.
This discovery is “without precedents” according to the investigation team who also hope that this study will provide a solution to substance dependence.
At this moment is time, the investigation team hold that at least 30 identified genes intervene in the control on drug dependence.
Scientists from the American National Institute on Drug Abuse, with the collaboration of Duke University have mapped-out, for the first time, a genetic sequence formed by hundreds of genes that allow us to predict how a smoker will respond to the different anti-tobacco treatments, above all those that replace nicotine addiction through pills, patches or gum over weekly or monthly periods.
Using the same method, the positive response to Bupropion, a common antidepressant that although doesn’t contain nicotine is used to contain nicotine anxiety by influencing the compensation circuits of the brain, can also be predicted.
Now investigators have more evidence that there exists a biological base not only for addiction but also for the capacity of a smoker to successfully give-up their addiction.
According to information published by “Time” magazine compiled by otr/press, scientists strongly advise professionals to also recommend therapy to smokers who wish to beat the habit of smoking.
Scientists also indicate that one method of stimulating the smoker patient in the process of treatment is to work with a “partner” that is also undergoing anti-nicotine treatment. This is in fact, the system being carried out in the study directed by Jed Rose, director of Duke University.
In this study, Rose and his team have studied 520,000 individual genes taken from smokers and non-smokers blood samples and determined that there is a gene profile that is implicated in the probability of a smoker being successful in breaking the nicotine habit.
The publication specifically highlights that some genes influence in the communication with the brain; others code broken enzymes in the body depending upon the anti-nicotine method used, that is to say, each of these genes “…have the same function; to help give-up smoking although each one does so in a different way”. “In this way, people whose genes code enzymes more efficiently respond better to medication” said the director of the study, whilst people with variant genetics which improve cell communication, have a higher disposition, in general to give-up smoking.
